Opdivo - International Biopharmaceutical Industry

Current Edition

news

As FDA scrutinizes immunotherapy approvals, Merck says Keytruda extends survival in liver cancer trial

The FDA has been under pressure to review the status of drugs granted accelerated approvals based on early data, as in some cases confirmatory trials haven't been com...

30 September 2021 news AstraZeneca | Bristol Myers Squibb

Continue Reading →

news

GSK, in race to catch up with rivals, wins expanded approval for cancer drug

GSK has high hopes for Jemperli as it transitions to what's being called the "new GSK," with a greater focus on experimental drugs for infectious disease, cancer and ...

20 August 2021 news Bristol Myers Squibb | cancer

Continue Reading →

news

Regeneron drug extends survival in lung cancer trial, lifting company’s hopes in field

Since its first approval in first-line lung cancer in 2016, Keytruda has proved a tough competitor for rival drugmakers to challenge with their own therapies. Bristol...

13 August 2021 news Bristol Myers Squibb | drugmakers

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

As FDA scrutinizes immunotherapy approvals, Merck says Keytruda extends survival in liver cancer trial

GSK, in race to catch up with rivals, wins expanded approval for cancer drug

Regeneron drug extends survival in lung cancer trial, lifting company’s hopes in field

International Biopharmaceutical Industry